Sinnar Bidi Udy. (509887)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹98.71 per share provides a measurable, though modest, asset base.
• The company is still a going concern with ₹1 Cr of sales in the latest quarter, not a shell.
• The stock at ₹769 is about 27% below its 52-week high, removing some speculative froth.
• Small market cap of ₹31 Cr leaves scope for a niche revival or corporate action if operations stabilise.

Concerns

• Sales growth fell 39.86% and latest quarterly sales were only ₹1 Cr, indicating rapid shrinkage.
• Profit growth of -200% and a net loss in the latest quarter eliminate any earnings support for the P/E of 159.58.
• ROCE of -4.72% and Piotroski F-Score of 2/9 point to capital destruction and weak financial health.
• Zero dividend, unavailable promoter holding and debt/equity data make governance and leverage unverifiable.

AI Analysis

Looking at Sinnar Bidi Udy, I see a business that fails nearly every test I apply. Sales are down 39.86%, profit growth is -200%, and the latest quarter shows only ₹1 Cr of revenue with a net loss. That is not a franchise; it is a business in distress. ROCE is -4.72%, meaning existing capital is being eroded, and ROE of 4.53% is barely above a savings rate. A company that cannot earn a respectable return on equity has no economic moat, no pricing power, and no reason for a premium valuation. The Piotroski F-Score of 2 out of 9 reinforces my unease. It points to weak profitability, deteriorating asset quality, and poor operating efficiency. The market cap is just ₹31 Cr and the book value is ₹98.71 per share, so at ₹769 the stock trades at 7.79 times book. That gives me no margin of safety. The P/E of 159.58 is meaningless because earnings have collapsed; you would be paying a very high multiple for a shrinking or loss-making business. What are the strengths? The company still has some book value and posted ₹1 Cr of sales in the latest quarter, so it is not a shell. The price has fallen to ₹769 from a high of ₹1,047, so some overvaluation has been corrected. But that is not enough. There is zero dividend, no promoter holding data, no debt-equity ratio, and insufficient information for a FairStock score. I cannot assess the people running the business, and in small companies that lack transparency, the danger is even greater. A true Graham investment should be bought cheaply with a margin of safety. This is expensive relative to assets and earnings power. The only path forward would be a genuine turnaround: stabilised sales, positive profits, and a much lower valuation. Until I see that, I will pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer